You have no items in your shopping cart.
Human GFRA2 [orb2994496]Unconjugated
Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 74.7 KDa. Observed: 120 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μg- Human GFRA1 [orb2993981]
Unconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 72.4 KDa. Observed: 85 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Human ACVR1 [orb2994792]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 12.6 KDa. Observed: 17 KDa, reducing conditions
1 mg, 10 μg, 50 μg, 500 μg - Human TGFBR1 [orb2992807]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 37.2 KDa. Observed: 38-58 KDa, reducing conditions
1 mg, 500 μg, 50 μg, 10 μg - Biotinylated Human TGF-beta 3 [orb2993088]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 14.5 KDa. Observed: 10-14 KDa, reducing conditions
100 μg, 20 μg - Biotinylated Human LAP [orb2993077]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 31.4 KDa. Observed: 35-45 KDa, reducing conditions
20 μg, 100 μg - Biotinylated Human TGF-beta 3 [orb2993078]
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 12.7&35.3 KDa. Observed: 12&37-45 KDa, reducing conditions
20 μg, 100 μg - Biotinylated Human TGF-beta 2 [orb2993079]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 12.7&36 KDa. Observed: 13&39-50 KDa, reducing conditions
20 μg, 100 μg - Biotinylated Mouse Latent TGF-beta 1 [orb2993080]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 12.8&31.7 KDa. Observed: 13&35-45 KDa, reducing conditions
100 μg, 20 μg - Rhesus Macaque Latent TGF-beta 1 [orb2993081]
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 12.8&31.4 KDa. Observed: 11&35-45 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg